Ingredion’s stock has fallen 12.9% over the past six months to $96.75, underperforming the S&P 500’s 7.8% gain, prompting a cautious outlook from analysts. The company’s revenue declined at an annual rate of 4.2% over the last three years, and Wall Street forecasts only 1.7% revenue growth over the next 12 months, below the sector average. Its free cash flow margin dropped by 7.1 percentage points to 6.2% over the trailing 12 months, signaling rising capital intensity. The stock trades at 8.6 times forward earnings, but analysts see better opportunities elsewhere given its shaky fundamentals.
Ingredion IncorporatedRevenue decline, weak growth forecast, falling free cash flow margin, and cautious analyst outlook.